Cargando…

Retinal microglia protect against vascular damage in a mouse model of retinopathy of prematurity

Retinopathy of prematurity (ROP) is a common cause of blindness in preterm babies. As a hypoxia-induced eye disease characterized by neovascularization, its association with retinal microglia has been noted but not well documented. We performed a comprehensive analysis of retinal microglia and retin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jin, Tsang, Jessica Kwan Wun, Fung, Frederic Khe Cheong, Chung, Sookja Kim, Fu, Zhongjie, Lo, Amy Cheuk Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431881/
https://www.ncbi.nlm.nih.gov/pubmed/36059936
http://dx.doi.org/10.3389/fphar.2022.945130
_version_ 1784780175566700544
author Liu, Jin
Tsang, Jessica Kwan Wun
Fung, Frederic Khe Cheong
Chung, Sookja Kim
Fu, Zhongjie
Lo, Amy Cheuk Yin
author_facet Liu, Jin
Tsang, Jessica Kwan Wun
Fung, Frederic Khe Cheong
Chung, Sookja Kim
Fu, Zhongjie
Lo, Amy Cheuk Yin
author_sort Liu, Jin
collection PubMed
description Retinopathy of prematurity (ROP) is a common cause of blindness in preterm babies. As a hypoxia-induced eye disease characterized by neovascularization, its association with retinal microglia has been noted but not well documented. We performed a comprehensive analysis of retinal microglia and retinal vessels in mouse oxygen-induced retinopathy (OIR), an animal model of ROP. In combination with a pharmacological inhibitory strategy, the role of retinal microglia in vascular network maintenance was investigated. Postnatal day (P) 7 C57BL/6J mouse pups with their nursing mother were exposed to 75% oxygen for 5 days to induce OIR. Age-matched room air-treated pups served as controls. On P12, P17, P21, P25, and P30, retinal microglia and vessels were visualized and quantified based on their location and activation status. Their relationship with retinal vessels was also analyzed. On P5 or P12, retinal microglia inhibition was achieved by intravitreal injection of liposomes containing clodronate (CLD); retinal vasculature and microglia were examined in P12 and P17 OIR retinae. The number of retinal microglia was increased in the superficial areas of OIR retinae on P12, P17, P21, P25, and P30, and most of them displayed an amoeboid (activated) morphology. The increased retinal microglia were associated with increased superficial retinal vessels in OIR retinae. The number of retinal microglia in deep retinal areas of OIR retinae also increased from P17 to P30 with a ramified morphology, which was not associated with reduced retinal vessels. Intravitreal injection of liposomes-CLD caused a significant reduction in retinal microglia. Loss of retinal microglia before hyperoxia treatment resulted in increased vessel obliteration on P12 and subsequent neovascularization on P17 in OIR retinae. Meanwhile, loss of retinal microglia immediately after hyperoxia treatment on P12 also led to more neovascularization in P17 OIR retinae. Our data showed that activated microglia were strongly associated with vascular abnormalities upon OIR. Retinal microglial activation continued throughout OIR and lasted until after retinal vessel recovery. Pharmacological inhibition of retinal microglia in either hyperoxic or hypoxic stage of OIR exacerbated retinal vascular consequences. These results suggested that retinal microglia may play a protective role in retinal vasculature maintenance in the OIR process.
format Online
Article
Text
id pubmed-9431881
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94318812022-09-01 Retinal microglia protect against vascular damage in a mouse model of retinopathy of prematurity Liu, Jin Tsang, Jessica Kwan Wun Fung, Frederic Khe Cheong Chung, Sookja Kim Fu, Zhongjie Lo, Amy Cheuk Yin Front Pharmacol Pharmacology Retinopathy of prematurity (ROP) is a common cause of blindness in preterm babies. As a hypoxia-induced eye disease characterized by neovascularization, its association with retinal microglia has been noted but not well documented. We performed a comprehensive analysis of retinal microglia and retinal vessels in mouse oxygen-induced retinopathy (OIR), an animal model of ROP. In combination with a pharmacological inhibitory strategy, the role of retinal microglia in vascular network maintenance was investigated. Postnatal day (P) 7 C57BL/6J mouse pups with their nursing mother were exposed to 75% oxygen for 5 days to induce OIR. Age-matched room air-treated pups served as controls. On P12, P17, P21, P25, and P30, retinal microglia and vessels were visualized and quantified based on their location and activation status. Their relationship with retinal vessels was also analyzed. On P5 or P12, retinal microglia inhibition was achieved by intravitreal injection of liposomes containing clodronate (CLD); retinal vasculature and microglia were examined in P12 and P17 OIR retinae. The number of retinal microglia was increased in the superficial areas of OIR retinae on P12, P17, P21, P25, and P30, and most of them displayed an amoeboid (activated) morphology. The increased retinal microglia were associated with increased superficial retinal vessels in OIR retinae. The number of retinal microglia in deep retinal areas of OIR retinae also increased from P17 to P30 with a ramified morphology, which was not associated with reduced retinal vessels. Intravitreal injection of liposomes-CLD caused a significant reduction in retinal microglia. Loss of retinal microglia before hyperoxia treatment resulted in increased vessel obliteration on P12 and subsequent neovascularization on P17 in OIR retinae. Meanwhile, loss of retinal microglia immediately after hyperoxia treatment on P12 also led to more neovascularization in P17 OIR retinae. Our data showed that activated microglia were strongly associated with vascular abnormalities upon OIR. Retinal microglial activation continued throughout OIR and lasted until after retinal vessel recovery. Pharmacological inhibition of retinal microglia in either hyperoxic or hypoxic stage of OIR exacerbated retinal vascular consequences. These results suggested that retinal microglia may play a protective role in retinal vasculature maintenance in the OIR process. Frontiers Media S.A. 2022-08-17 /pmc/articles/PMC9431881/ /pubmed/36059936 http://dx.doi.org/10.3389/fphar.2022.945130 Text en Copyright © 2022 Liu, Tsang, Fung, Chung, Fu and Lo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liu, Jin
Tsang, Jessica Kwan Wun
Fung, Frederic Khe Cheong
Chung, Sookja Kim
Fu, Zhongjie
Lo, Amy Cheuk Yin
Retinal microglia protect against vascular damage in a mouse model of retinopathy of prematurity
title Retinal microglia protect against vascular damage in a mouse model of retinopathy of prematurity
title_full Retinal microglia protect against vascular damage in a mouse model of retinopathy of prematurity
title_fullStr Retinal microglia protect against vascular damage in a mouse model of retinopathy of prematurity
title_full_unstemmed Retinal microglia protect against vascular damage in a mouse model of retinopathy of prematurity
title_short Retinal microglia protect against vascular damage in a mouse model of retinopathy of prematurity
title_sort retinal microglia protect against vascular damage in a mouse model of retinopathy of prematurity
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431881/
https://www.ncbi.nlm.nih.gov/pubmed/36059936
http://dx.doi.org/10.3389/fphar.2022.945130
work_keys_str_mv AT liujin retinalmicrogliaprotectagainstvasculardamageinamousemodelofretinopathyofprematurity
AT tsangjessicakwanwun retinalmicrogliaprotectagainstvasculardamageinamousemodelofretinopathyofprematurity
AT fungfrederickhecheong retinalmicrogliaprotectagainstvasculardamageinamousemodelofretinopathyofprematurity
AT chungsookjakim retinalmicrogliaprotectagainstvasculardamageinamousemodelofretinopathyofprematurity
AT fuzhongjie retinalmicrogliaprotectagainstvasculardamageinamousemodelofretinopathyofprematurity
AT loamycheukyin retinalmicrogliaprotectagainstvasculardamageinamousemodelofretinopathyofprematurity